H

HaTay Pharmaceutical JSC
VN:DHT

Watchlist Manager
HaTay Pharmaceutical JSC
VN:DHT
Watchlist
Price: 95 700 VND 0.84% Market Closed
Market Cap: 7.9T VND
Have any thoughts about
HaTay Pharmaceutical JSC?
Write Note

Net Margin
HaTay Pharmaceutical JSC

3.4%
Current
4%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.4%
=
Net Income
68.3B
/
Revenue
2T

Net Margin Across Competitors

Country VN
Market Cap 7.9T VND
Net Margin
3%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 757B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 2.7T DKK
Net Margin
35%
Country US
Market Cap 350.9B USD
Net Margin
17%
Country US
Market Cap 252.8B USD
Net Margin
19%
Country CH
Market Cap 200.1B CHF
Net Margin
20%
Country UK
Market Cap 161.8B GBP
Net Margin
13%
Country CH
Market Cap 171.5B CHF
Net Margin
35%
Country US
Market Cap 150.9B USD
Net Margin
7%
No Stocks Found

HaTay Pharmaceutical JSC
Glance View

Market Cap
7.9T VND
Industry
Pharmaceuticals

Ha Tay Pharmaceutical JSC engages in the manufacture, import and export of drugs, medicine, cosmetic and medical equipment. The company is headquartered in Hanoi, Hanoi. The company went IPO on 2008-12-03. The company is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The firm also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The firm announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.

DHT Intrinsic Value
18 592.65 VND
Overvaluation 81%
Intrinsic Value
Price
H

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.4%
=
Net Income
68.3B
/
Revenue
2T
What is the Net Margin of HaTay Pharmaceutical JSC?

Based on HaTay Pharmaceutical JSC's most recent financial statements, the company has Net Margin of 3.4%.